BRPI0411582A - substáncias terapêuticas contendo boro hidroliticamente resistentes e método de uso - Google Patents

substáncias terapêuticas contendo boro hidroliticamente resistentes e método de uso

Info

Publication number
BRPI0411582A
BRPI0411582A BRPI0411582-1A BRPI0411582A BRPI0411582A BR PI0411582 A BRPI0411582 A BR PI0411582A BR PI0411582 A BRPI0411582 A BR PI0411582A BR PI0411582 A BRPI0411582 A BR PI0411582A
Authority
BR
Brazil
Prior art keywords
therapeutic substances
containing therapeutic
hydrolytically resistant
resistant boron
compositions
Prior art date
Application number
BRPI0411582-1A
Other languages
English (en)
Inventor
Ving Lee
Jacob J Plattner
Stephen J Benkovic
Stephen J Baker
Kirk R Maples
Carolyn Bellinger-Kawahara
Tsutomu Akama
Yong-Kang Zhang
Rejeshwar Singh
Vittorio Sauro
Original Assignee
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc
Publication of BRPI0411582A publication Critical patent/BRPI0411582A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"SUBSTáNCIAS TERAPêUTICAS CONTENDO BORO HIDROLITICAMENTE RESISTENTES E MéTODO DE USO". São reveladas composições e métodos de uso de derivados de boro, incluindo benzoxaboros, benzazaboros e benztiaboros, como agentes terapêuticos para o tratamento de doenças causadas por bactérias ou vírus, assim como métodos para a síntese dos agentes e composições desses.
BRPI0411582-1A 2003-06-16 2004-06-15 substáncias terapêuticas contendo boro hidroliticamente resistentes e método de uso BRPI0411582A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47892103P 2003-06-16 2003-06-16
PCT/US2004/018765 WO2005013892A2 (en) 2003-06-16 2004-06-15 Hydrolytically-resistant boron-containing therapeutics and methods of use

Publications (1)

Publication Number Publication Date
BRPI0411582A true BRPI0411582A (pt) 2006-08-08

Family

ID=34135048

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411582-1A BRPI0411582A (pt) 2003-06-16 2004-06-15 substáncias terapêuticas contendo boro hidroliticamente resistentes e método de uso

Country Status (12)

Country Link
US (2) US7465836B2 (pt)
EP (1) EP1638578A4 (pt)
CN (1) CN1829521B (pt)
AU (1) AU2004262524C1 (pt)
BR (1) BRPI0411582A (pt)
CA (1) CA2529792A1 (pt)
IL (1) IL172627A0 (pt)
MX (1) MXPA05013848A (pt)
NZ (1) NZ544245A (pt)
RU (2) RU2006101228A (pt)
WO (1) WO2005013892A2 (pt)
ZA (1) ZA200600387B (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7465836B2 (en) * 2003-06-16 2008-12-16 Anacor Pharmaceuticals, Inc. Hydrolytically-resistant boron-containing therapeutics and methods of use
US7767657B2 (en) 2005-02-16 2010-08-03 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
SI3424932T1 (sl) * 2005-02-16 2021-08-31 Anacor Pharmaceuticals, Inc. Boronoftalidi za terapevtsko uporabo
MX335993B (es) * 2005-12-30 2016-01-07 Anacor Pharmaceuticals Inc Moleculas pequeñas que contienen boro.
HRP20150710T1 (hr) 2006-02-16 2015-08-14 Anacor Pharmaceuticals, Inc. Male molekule koje sadrže bor kao protu-upalni agensi
BRPI0711155A2 (pt) * 2006-05-02 2011-08-23 Anacor Pharmaceuticals Inc terapêuticos contendo boro resistentes hidroliticamente e métodos de uso
EP1900378A1 (en) * 2006-08-31 2008-03-19 Novartis AG Pharmaceutical compositions for the treatment of fungal infections
JO3598B1 (ar) 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
JO3396B1 (ar) 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
BRPI0818773A2 (pt) * 2007-10-19 2015-04-14 Janssen Pharmaceutica Nv Moduladores de gama-secretase ligados a carbono
RU2015109165A (ru) * 2008-03-06 2015-11-10 Анакор Фармасьютикалз, Инк. Борсодержащие малые молекулы в качестве противовоспалительных агентов
CN102046179B (zh) 2008-04-09 2015-01-14 英菲尼提制药公司 脂肪酸酰胺水解酶抑制剂
CA2720587A1 (en) 2008-04-09 2009-10-15 Francis Barany Coferons and methods of making and using them
US20100256092A1 (en) * 2008-05-12 2010-10-07 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2010027975A1 (en) * 2008-09-04 2010-03-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2010028005A1 (en) 2008-09-04 2010-03-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2010045503A1 (en) 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
CN102256494A (zh) 2008-12-17 2011-11-23 阿纳科制药公司 (s)-3-氨甲基-7-(3-羟基-丙氧基)-3h-苯并[c][1,2]氧杂硼杂环戊-1-醇的多晶型物
AU2010234449A1 (en) 2009-04-07 2011-11-03 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8546564B2 (en) 2009-04-07 2013-10-01 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
JP2013500974A (ja) 2009-07-28 2013-01-10 アナコール ファーマシューティカルズ，インコーポレイテッド 三置換ホウ素含有分子
US9440994B2 (en) 2009-08-14 2016-09-13 Anacor Pharmaceuticals, Inc. Boron containing small molecules as antiprotozoal agents
WO2011022337A1 (en) * 2009-08-19 2011-02-24 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
WO2011037731A1 (en) * 2009-09-25 2011-03-31 Anacor Pharmaceuticals, Inc. Boron containing small molecules
CA2774476A1 (en) 2009-10-07 2011-04-14 Francis Barany Coferons and methods of making and using them
US9346834B2 (en) 2009-10-20 2016-05-24 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
WO2011060199A1 (en) 2009-11-11 2011-05-19 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2011094450A1 (en) 2010-01-27 2011-08-04 Anacor Pharmaceuticals, Inc Boron-containing small molecules
JP2013518886A (ja) 2010-02-03 2013-05-23 インフイニトイ プハルマセウトイカルス インコーポレイテッド 脂肪酸アミドヒドロラーゼ阻害剤
US8623911B2 (en) 2010-03-19 2014-01-07 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agent
PT3251678T (pt) 2010-09-07 2021-11-22 Anacor Pharmaceuticals Inc Derivados de benzoxaborol para tratamento de infeções bacterianas
US8530452B2 (en) 2011-12-22 2013-09-10 Micurx Pharmaceuticals, Inc. Tricyclic boron compounds for antimicrobial therapy
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
KR101666331B1 (ko) 2013-01-30 2016-10-13 다우 아그로사이언시즈 엘엘씨 육류, 식물, 또는 식물 부분에 대한 휘발성 항미생물제로서의 벤족사보롤의 용도
EP2994142A4 (en) * 2013-05-08 2017-03-29 Colorado Seminary, Which Owns and Operates The University of Denver Antibiotic and anti-parasitic agents that modulate class ii fructose 1,6-bisphosphate aldolase
WO2016001834A1 (en) 2014-07-01 2016-01-07 Daiichi Sankyo Company, Limited Tricyclic benzoxaboroles as antibacterial agents
RU2017131724A (ru) 2015-02-12 2019-03-12 Агрофреш, Инк. Фунгицидные соединения и композиции
US10160867B2 (en) * 2015-08-06 2018-12-25 The Penn State Research Foundation Benzoxaborole-containing coating resistant to cellulose-supportable fungus
NZ745681A (en) 2016-03-07 2022-05-27 Agrofresh Inc Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
US11447506B2 (en) 2016-05-09 2022-09-20 Anacor Pharmaceuticals, Inc. Crystal forms of crisaborole in free form and preparation method and use thereof
EP3609504A4 (en) 2017-03-01 2021-03-03 Anacor Pharmaceuticals, Inc. NEW OXABOROLE ANALOGUES AND USES OF THE LATEST
CA3111328A1 (en) 2018-09-12 2020-03-19 Institut National De La Recherche Scientifique Compounds and methods for the treatment of pathogenic neisseria
CN110183477B (zh) * 2019-07-03 2022-03-04 石家庄诚志永华显示材料有限公司 有机电致发光化合物及其应用
US20230340530A1 (en) 2020-08-31 2023-10-26 Pfizer Inc. Methods of Protecting RNA
CN113150022B (zh) * 2021-04-23 2022-12-06 四川大学 3-取代五元环状硼酸酯衍生物及其药物组合物和制药用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411587D0 (en) * 1994-06-09 1994-08-03 Zeneca Ltd Compound, composition and use
CA2225014A1 (en) * 1997-12-16 1999-06-16 Peter Zoricak B-n heterocyclic ligands
EP1444981A1 (en) * 2001-10-11 2004-08-11 Katsuhiko Mikoshiba Intracellular calcium concentration increase inhibitors
US7465836B2 (en) * 2003-06-16 2008-12-16 Anacor Pharmaceuticals, Inc. Hydrolytically-resistant boron-containing therapeutics and methods of use

Also Published As

Publication number Publication date
US20090239824A1 (en) 2009-09-24
RU2006101228A (ru) 2006-07-27
CA2529792A1 (en) 2005-02-17
RU2009139904A (ru) 2011-05-10
US7465836B2 (en) 2008-12-16
AU2004262524C1 (en) 2010-08-19
CN1829521A (zh) 2006-09-06
EP1638578A4 (en) 2009-04-01
AU2004262524B2 (en) 2010-03-11
MXPA05013848A (es) 2006-09-04
ZA200600387B (en) 2009-06-24
AU2004262524A1 (en) 2005-02-17
CN1829521B (zh) 2011-01-26
WO2005013892A9 (en) 2005-04-14
US7968752B2 (en) 2011-06-28
IL172627A0 (en) 2006-04-10
US20050054644A1 (en) 2005-03-10
WO2005013892A2 (en) 2005-02-17
EP1638578A2 (en) 2006-03-29
NZ544245A (en) 2010-04-30
WO2005013892A3 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
BRPI0411582A (pt) substáncias terapêuticas contendo boro hidroliticamente resistentes e método de uso
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
BR0309875A (pt) métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto
BRPI0409969A (pt) composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto
SE0202539D0 (sv) Compounds
WO2007131072A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
SE0104140D0 (sv) Novel Compounds
TW200508214A (en) Novel compounds
AU2002314914A1 (en) Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
BRPI0410316A (pt) composto, composição farmacêutica, uso dos compostos, e, método de tratamento de distúrbios mediados por vr1 e para o tratamento de distúrbios de dores
BR0317358A (pt) Composto de pirrolopiridazina, processo para sua preparação, composição farmacêutica contendo o mesmo, método de prevenção ou tratamento de doenças contendo o mesmo e seu uso
SE0300480D0 (sv) Novel compounds
DE60305484D1 (de) Verbindungen und deren verwendung als 5-ht inhibitore
BR0309343A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
MA31567B1 (fr) Derives de 7 -alkynyl-1.8-naphthyrid0nes, leur preparation et leur application en therapeutique
SE0302139D0 (sv) Novel compounds
ATE457027T1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht
BR0311491A (pt) Composto, composição farmacêutica, uso de um composto, e, método terapêutico para tratar câncer em um mamìfero
SE0401763D0 (sv) Compounds
SE0303280D0 (sv) Novel compounds
NO20053809L (no) Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
MXPA02012426A (es) Compuestos nuevos.
TW200740781A (en) Novel compounds
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.